| Characteristics | Number | Percentage (%) |
| Age (in years) |
|
|
| <5 years | 85 | 40.47 |
| 5 - 10 years | 86 | 40.95 |
| >10 years | 39 | 18.57 |
| Sex |
|
|
| Female | 93 | 44.3 |
| Male | 117 | 55.7 |
| OMS clinical Stage |
|
|
| Stage 1 | 8 | 3.8 |
| Stage 2 | 65 | 31 |
| Stage 3 | 103 | 49 |
| Stage 4 | 34 | 16 |
| Immunological status | 128 |
|
| *L TCD4 < 15% | 94 | 73.43 |
| LTCD4 15% - 25% | 24 | 18.75 |
| LTCD4 > 25% | 10 | 7.8 |
| Statural growth |
|
|
| Normal | 120 | 57.14 |
| Moderate delay | 55 | 26.3 |
| Severe delay | 35 | 16.66 |
| Ponderal growth |
|
|
| Normal | 130 | 61.9 |
| Moderate delay | 55 | 26.19 |
| Severe delay | 25 | 11.9 |